Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery

Orthocell Expands Remplir's Use in Prostate Cancer Surgeries

Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery

Potential to reduce the risk of erectile dysfunction and urinary incontinence

Orthocell’s Remplir used in nerve-sparing prostate surgery

Australian urologists are now using Orthocell’s flagship nerve repair product during prostate cancer surgery in what the WA biotech says has potential to reduce the risks of erectile dysfunction.

Orthocell adds to Remplir use cases

WA biotech Orthocell has announced a promising new use case for its Remplir nerve regeneration product, this time in reducing post-surgical complications in prostate cancer sufferers.

Orthocell’s Remplir used in nerve-sparing prostate cancer surgery

Australian urologists are using Orthocell’s flagship nerve repair product Remplir in prostate cancer surgery Remplir holds promise in reducing post-surgical complications due to peripheral nerve injury Up to 80% of men experience erectile dysfunction and up to 35% suffer from urinary incontinence following radical proctectomy   Special Report: Australian urologists are now using Orthocell’s flagship nerve repair product Remplir during prostate c…